This content is machine translated Multiple myeloma DREAMM-7: Belamaf plus bortezomib and dexamethasone outperforms comparator therapy In patients with multiple myeloma, the disease is often refractory to first-line triple or quadruple therapies. The result: a relapse occurs. Therefore, effective second-line therapy combinations are needed that include...…
View Post 3 min This content is machine translated Vasculitides Interdisciplinary clarification essential for differential diagnosis An update on practice recommendations for the management of vasculitis was presented at the 2019 American Academy of Dermatology Annual Meeting. An interdisciplinary vasculitis consultation is offered at the USZ.…
View Post 5 min This content is machine translated 13th Zurich Hypertension Day The difficult to adjust blood pressure 50% of hypertensives are not well controlled with prescribed medications, and about 40% of sufferers in Switzerland are not diagnosed at all. Thilo Burkard, MD, spoke at the Zurich Hypertension…
View Post 4 min This content is machine translated Multiple Myeloma and MDS Something has happened in therapy The diagnosis and treatment of multiple myeloma (MM) and myelodysplastic syndromes (MDS) have undergone great development in recent years. Modern diagnostic procedures became qualitatively better and more widely available, new…
